Outcomes of Hospitalized Patients with Glucocorticoid-Induced Hyperglycemia—A Retrospective Analysis
Open Access
- 17 December 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (12) , 4079
Abstract
Background: Glucocorticoid (GC)-induced hyperglycemia is a frequent side effect in hospitalized patients. Guidelines recommend treat-to-target treatment between 6–10 mmol/L (108–180 mg/dL) with insulin, but data on outcome is scarce. We investigated the 30-day outcome in hospitalized patients receiving GCs. Methods: All patient records of hospitalized patients between January 2014 and April 2018 were screened for GC administration and consecutive hyperglycemia. The primary combined endpoint consisted of death, cardiovascular events, and infections until 30 days after admission. Hypoglycemia was a secondary outcome. Results: Of the 2424 hospitalized patients (9.6% of all hospitalized patients) who received systemic GCs and met inclusion criteria, the overall incidence for GC-induced hyperglycemia was 812 (33.5%), and 89 (3.7%) had at least one documented hypoglycemia during their hospital stay. Compared to patients with normoglycemia, GC-induced hyperglycemia had an adjusted-odds ratio of 1.68 (95% CI 1.25–2.26) for the combined primary endpoint. Hypoglycemia even had an odds ratio of 1.95 (95% CI 1.2–3.17). Conclusions: Mortality, cardiovascular events, and rate of infections were markedly higher in patients with GC-induced hyperglycemia as compared to patients with normoglycemia. Importantly, hypoglycemia was associated with a doubled risk for adverse outcome. Future studies should evaluate whether optimized glucose control by minimizing the risk for hypoglycemia has a beneficial effect on clinical outcomes in patients with GC-induced hyperglycemia.Keywords
Funding Information
- Helmut Horten Stiftung (n.a.)
- Swiss Society of Endocrinology and Diabetology SGED/SSED (Young Independent Investigator Grant 2016)
This publication has 44 references indexed in Scilit:
- Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspectiveDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Postoperative tight glycemic control significantly reduces postoperative infection rates in patients undergoing surgery: a meta-analysisBMC Endocrine Disorders, 2018
- The influence on survival of glucocorticoid induced diabetes in cancer patients with metastatic spinal cord compressionClinical and Translational Radiation Oncology, 2018
- Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trialThe Lancet, 2015
- Hyperglycemia Induced by Glucocorticoids in Nondiabetic Patients: A Meta-AnalysisAnnals of Nutrition and Metabolism, 2014
- Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2012
- Glycemic Control in Non-Critically Ill Hospitalized Patients: A Systematic Review and Meta-AnalysisThe Journal of Clinical Endocrinology & Metabolism, 2012
- Intensive versus Conventional Glucose Control in Critically Ill PatientsNew England Journal of Medicine, 2009
- Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old DrugsNew England Journal of Medicine, 2005
- Intensive Insulin Therapy in Critically Ill PatientsNew England Journal of Medicine, 2001